Christiana Stamoulis
President and Chief Financial Officer
Christiana Stamoulis serves as the company’s President and CFO, a role she assumed in September 2025. She brings 30 years of experience in the biotechnology industry, with expertise in corporate finance, capital markets, strategy, and the origination, structuring, and execution of strategic partnerships and M&A transactions.
Ms. Stamoulis joined the company as President and CFO in September 2025. Before joining Keenova, she served since February 2019 as Executive Vice President and CFO of Incyte Corp., a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics from February 2019 to September 2025.
Prior to Incyte, she was President and CFO of Unum Therapeutics, a biopharmaceutical company. Prior to joining Unum, Ms. Stamoulis was a Senior Vice President of Corporate Strategy and Business Development at Vertex Pharmaceuticals. Prior to Vertex, Ms. Stamoulis spent nearly 15 years as an investment banker and management consultant, serving as a Managing Director in Citigroup's Investment Banking division and a senior investment banker in the Healthcare Investment Banking Group at Goldman Sachs. She began her career as a strategy consultant at The Boston Consulting Group.
From November 2011 to April 2026, Ms. Stamoulis served on the Board of Directors of Hologic Inc., a medical technology company. She holds two Bachelor of Science degrees from the Massachusetts Institute of Technology (MIT) and an MBA from the MIT Sloan School of Management.